About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 417 record(s)
Req # A-2022-001641
Adverse Drug Reactions (ADRs). Report numbers: E2B_05325210, E2B_05374888, E2B_05325164, E2B_03862542 , E2B_05363081, E2B_05376108, E2B_05376106.Organization: Health Canada
June 2023
Req # A-2022-001656
Adverse Drug Reactions (ADRs). Report numbers: E2B_04563850, E2B_05797057, E2B_05792498, E2B_05794382, E2B_05755755, E2B_05752231, E2B_05746814, E2B_05734896, E2B_05717293, 001012177.Organization: Health Canada
June 2023
Req # A-2022-001658
Adverse Drug Reactions (ADRs). Report numbers: E2B_05743555, E2B_05751416, E2B_05743165, E2B_05793147, E2B_05748564, E2B_05667804, E2B_05749079, E2B_05749098, 001012304, 001012256.Organization: Health Canada
June 2023
Req # A-2022-001659
Adverse Drug Reactions (ADRs). Report numbers: E2B_05785440, E2B_05784990, E2B_05784962, E2B_02856303, E2B_02732043, E2B_05073443, E2B_03813240, E2B_05661743, E2B_05711934.Organization: Health Canada
June 2023
Req # A-2022-001660
Adverse Drug Reactions (ADRs). Report numbers: E2B_01850517, E2B_01772163, E2B_05704118, E2B_02502002, E2B_02987919, E2B_05605829, E2B_04127815, E2B_05703028, E2B_05006894, E2B_05716715.Organization: Health Canada
June 2023
Req # A-2022-001664
Adverse Drug Reactions (ADRs). Report numbers: E2B_05717691, E2B_05716718, E2B_05717118, E2B_05749245, E2B_04563399, E2B_05650995, E2B_03563778, 001003189, 000998828, 001005192.Organization: Health Canada
June 2023
Req # A-2022-001681
Adverse Drug Reactions (ADRs). Report numbers: E2B_05869334, E2B_05873004, 001021090, 001013652, 001015153, E2B_05859651, 001014700, E2B_05838445, E2B_05858978, E2B_05858927.Organization: Health Canada
June 2023
Req # A-2022-001683
Adverse Drug Reactions (ADRs). Report numbers: E2B_05817993, E2B_05818155, E2B_05651560, E2B_04402032, E2B_05862191, E2B_05862242, E2B_05858928, E2B_05862192, E2B_02743023, E2B_05862158.Organization: Health Canada
June 2023
Req # A-2023-000003
Adverse Drug Reaction (ADR) for DEXILANT. Report number: E2B_06057113. ADRs for ENTYVIO. Report numbers: E2B_06095780, E2B_06028666, E2B_06112587, E2B_06090313. ADRs for VEDOLIZUMAB. Report numbers: E2B_06030605, 001024450. ADRs for ONDANSETRON. Report numbers: 001022983, E2B_06107693, E2B_06113147.Organization: Health Canada
June 2023
Req # A-2023-000040
Adverse Drug Reactions (ADRs). Report numbers: E2B_06110338, E2B_06076856, E2B_06100963, E2B_06062081, 001025690, 001026451, E2B_06066885, 001023817, 001026959, E2B_06073935.Organization: Health Canada
June 2023